Benjamin T. Marchello

Montana Cancer Consortium

$6,497,536

Attributed

$8,339,423

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $943.4K · FY2005–18

$1M$750K$500K$250K$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

Funding mix

By agency

NIH$8,339,423 · 2

By mechanism

U10$4,655,648 · 1

UG1$3,683,775 · 1

Top collaborators

John M. Schallenkamp5 shared

Most similar at Montana Cancer Consortium

Same institution · by research overlap

Others in their field

Top investigators on “Malignant Neoplasms”

David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
Richard K. Wilson · Washington University$274,272,747
Larry Arthur$223,443,122
Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879

Research focus

Malignant NeoplasmsCancer TherapySiteCancer ControlPhysiciansCancer CareParticipantRural PopulationCommunity Clinical Oncology ProgramWyomingMedicalMontanaProtocols DocumentationAreaBaseClinical TrialsHome EnvironmentRadiation OncologistFundingHealth Services AccessibilityPreventionIndian ReservationOncologistClinic